2005
DOI: 10.1253/circj.69.121
|View full text |Cite
|
Sign up to set email alerts
|

Surgical Treatment for Primary Cardiac Leiomyosarcoma Causing Right Ventricular Outflow Obstruction

Abstract: rimary cardiac leiomyosarcoma is extremely rare, constituting less than 0.25% of all cardiac tumors, 1 but it has a lethal prognosis even if surgical resection, with or without adjuvant therapy, is performed. 2,3 Only a few cases of surgical resection of cardiac leiomyosarcoma have been reported. 4 We present a case of surgical resection of a primary cardiac leiomyosarcoma involving the pulmonary valve, which was reconstructed with a bioprosthetic valve and Xenomedica patch. Case ReportA 55-year-man was admitt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…4,7,9-11 TEE, CT, and CMR offer additional information about the size, location, attachment, and local spread of the tumor. 4,7,[9][10][11] However, it is not easy to discriminate between malignant and benign cardiac tumors before histological examination. 5,7 Recently, PET-CT has been a preferred method to use to evaluate the local invasion and distant metastasis of malignant cardiac tumors.…”
Section: Discussionmentioning
confidence: 99%
“…4,7,9-11 TEE, CT, and CMR offer additional information about the size, location, attachment, and local spread of the tumor. 4,7,[9][10][11] However, it is not easy to discriminate between malignant and benign cardiac tumors before histological examination. 5,7 Recently, PET-CT has been a preferred method to use to evaluate the local invasion and distant metastasis of malignant cardiac tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Pulmonary valvular function has been reconstructed using a bioprosthetic valve. 11,12 We implanted a stentless valve instead of a mono-cusped biomaterial patch to obtain competent pulmonary valvular function because the patient needed suffi cient valvular function to maintain pulmonary blood fl ow against pulmonary hypertension resulting from distal tumor microembolization. Also, patch enlargement of the pulmonary arteries, which would delay pulmonary artery reobstruction by the tumor growth, seemed effective in lengthening the survival of our patient.…”
Section: Discussionmentioning
confidence: 99%